West Pharmaceutical Services Stock Buy Hold or Sell Recommendation
| WST Stock | USD 320.88 9.22 2.96% |
Considering the 90-day investment horizon and your conservative attitude towards risk, our recommendation regarding West Pharmaceutical Services is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell West Pharmaceutical Services given historical horizon and risk tolerance towards West Pharmaceutical. When Macroaxis issues a 'buy' or 'sell' recommendation for West Pharmaceutical Services, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out West Pharmaceutical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as West and provide practical buy, sell, or hold advice based on investors' constraints. West Pharmaceutical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
West |
Execute West Pharmaceutical Buy or Sell Advice
The West recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on West Pharmaceutical Services. Macroaxis does not own or have any residual interests in West Pharmaceutical Services or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute West Pharmaceutical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
West Pharmaceutical Trading Alerts and Improvement Suggestions
| West Pharmaceutical is unlikely to experience financial distress in the next 2 years | |
| West Pharmaceutical has a strong financial position based on the latest SEC filings | |
| Over 97.0% of the company outstanding shares are owned by institutional investors | |
| On 20th of November 2024 West Pharmaceutical paid $ 0.21 per share dividend to its current shareholders | |
| Latest headline from prnewswire.com: OLYBET se asocia con WST |
West Pharmaceutical Returns Distribution Density
The distribution of West Pharmaceutical's historical returns is an attempt to chart the uncertainty of West Pharmaceutical's future price movements. The chart of the probability distribution of West Pharmaceutical daily returns describes the distribution of returns around its average expected value. We use West Pharmaceutical Services price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of West Pharmaceutical returns is essential to provide solid investment advice for West Pharmaceutical.
| Mean Return | 0.10 | Value At Risk | -3.02 | Potential Upside | 4.50 | Standard Deviation | 2.88 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of West Pharmaceutical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
West Stock Institutional Investors
The West Pharmaceutical's institutional investors refer to entities that pool money to purchase West Pharmaceutical's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.3 M | Proshare Advisors Llc | 2024-09-30 | 1.1 M | Durable Capital Partners Lp | 2024-06-30 | 1 M | Jpmorgan Chase & Co | 2024-06-30 | 909.1 K | Norges Bank | 2024-06-30 | 866.4 K | T. Rowe Price Investment Management,inc. | 2024-09-30 | 839.3 K | Findlay Park Partners Llp | 2024-09-30 | 827.7 K | Bamco Inc | 2024-06-30 | 763.2 K | Ubs Asset Mgmt Americas Inc | 2024-09-30 | 683.4 K | Vanguard Group Inc | 2024-09-30 | 9 M | Blackrock Inc | 2024-06-30 | 7.6 M |
West Pharmaceutical Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (18.6M) | (73.7M) | (86.5M) | (49.8M) | (13.5M) | (14.2M) | |
| Change In Cash | 101.7M | 176.4M | 147.1M | 131.7M | (40.4M) | (38.4M) | |
| Free Cash Flow | 240.8M | 298.1M | 330.6M | 439.4M | 414.5M | 435.2M | |
| Depreciation | 103.4M | 109.1M | 122.3M | 120.6M | 137.3M | 144.2M | |
| Other Non Cash Items | (3.2M) | (700K) | (900K) | 36.1M | 5.4M | 3.5M | |
| Dividends Paid | 45.1M | 48.1M | 51.1M | 54.1M | 57M | 59.9M | |
| Capital Expenditures | 126.4M | 174.4M | 253.4M | 284.6M | 362M | 380.1M | |
| Net Income | 241.7M | 346.2M | 661.8M | 585.9M | 593.4M | 623.1M | |
| End Period Cash Flow | 439.1M | 615.5M | 762.6M | 894.3M | 853.9M | 896.6M | |
| Investments | (85.1M) | (179.5M) | (253.1M) | (288.2M) | (354.7M) | (337.0M) | |
| Change Receivables | (33.3M) | (46.6M) | (123.5M) | (35.6M) | (32.0M) | (33.6M) | |
| Net Borrowings | 60.9M | (2.3M) | (2.2M) | (45.5M) | (52.3M) | (49.7M) | |
| Change To Netincome | 37.3M | 23.8M | (19.7M) | 29.7M | 34.2M | 26.6M |
West Pharmaceutical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to West Pharmaceutical or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that West Pharmaceutical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a West stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.0003 | |
β | Beta against Dow Jones | 1.09 | |
σ | Overall volatility | 2.96 | |
Ir | Information ratio | 0 |
West Pharmaceutical Volatility Alert
West Pharmaceutical Services currently demonstrates below-average downside deviation. It has Information Ratio of 0.0 and Jensen Alpha of 0.0. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure West Pharmaceutical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact West Pharmaceutical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.West Pharmaceutical Fundamentals Vs Peers
Comparing West Pharmaceutical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze West Pharmaceutical's direct or indirect competition across all of the common fundamentals between West Pharmaceutical and the related equities. This way, we can detect undervalued stocks with similar characteristics as West Pharmaceutical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of West Pharmaceutical's fundamental indicators could also be used in its relative valuation, which is a method of valuing West Pharmaceutical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare West Pharmaceutical to competition |
| Fundamentals | West Pharmaceutical | Peer Average |
| Return On Equity | 0.18 | -0.31 |
| Return On Asset | 0.1 | -0.14 |
| Profit Margin | 0.17 % | (1.27) % |
| Operating Margin | 0.22 % | (5.51) % |
| Current Valuation | 22.39 B | 16.62 B |
| Shares Outstanding | 72.42 M | 571.82 M |
| Shares Owned By Insiders | 0.58 % | 10.09 % |
| Shares Owned By Institutions | 96.60 % | 39.21 % |
| Number Of Shares Shorted | 1.43 M | 4.71 M |
| Price To Earning | 40.71 X | 28.72 X |
| Price To Book | 8.20 X | 9.51 X |
| Price To Sales | 7.85 X | 11.42 X |
| Revenue | 2.95 B | 9.43 B |
| Gross Profit | 1.14 B | 27.38 B |
| EBITDA | 847.8 M | 3.9 B |
| Net Income | 593.4 M | 570.98 M |
| Cash And Equivalents | 894.3 M | 2.7 B |
| Cash Per Share | 9.85 X | 5.01 X |
| Total Debt | 309 M | 5.32 B |
| Debt To Equity | 0.12 % | 48.70 % |
| Current Ratio | 3.80 X | 2.16 X |
| Book Value Per Share | 37.96 X | 1.93 K |
| Cash Flow From Operations | 776.5 M | 971.22 M |
| Short Ratio | 1.83 X | 4.00 X |
| Earnings Per Share | 6.73 X | 3.12 X |
| Price To Earnings To Growth | 5.82 X | 4.89 X |
| Target Price | 361.57 | |
| Number Of Employees | 10.6 K | 18.84 K |
| Beta | 1.0 | -0.15 |
| Market Capitalization | 22.57 B | 19.03 B |
| Total Asset | 3.83 B | 29.47 B |
| Retained Earnings | 3.52 B | 9.33 B |
| Working Capital | 1.26 B | 1.48 B |
Note: Disposition of 584 shares by Annette Favorite of West Pharmaceutical subject to Rule 16b-3 [view details]
West Pharmaceutical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as West . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 17070.82 | |||
| Daily Balance Of Power | 0.7254 | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 314.82 | |||
| Day Typical Price | 316.84 | |||
| Price Action Indicator | 10.67 | |||
| Period Momentum Indicator | 9.22 | |||
| Relative Strength Index | 51.34 |
About West Pharmaceutical Buy or Sell Advice
When is the right time to buy or sell West Pharmaceutical Services? Buying financial instruments such as West Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having West Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Investment Grade ETFs Thematic Idea Now
Investment Grade ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Investment Grade ETFs theme has 257 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investment Grade ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for West Stock Analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.